2Schwertner H A, Fischer J R. Comparision of various lipid, lipoprotein, and bilirubin combinations as risk factors for predicting coronary artery disease. Atherosclerosis, 2000,150: 381- 387.
3Breimer L H, Wannamethee G, Ebrahim S, et al. Serum bilirubin and risk of ischemic heart disease in middle-aged British man. Clin Chem, 1995,41:1504-1508.
4Schwertner H A, Jackson W G,Tolan G. Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin Chem, 1994,40:18-23.
5Han K H, Chang I K, Boullier A, et al. Oxidized LDL reduces monocyte CCR2 expression through pathways involving peroxisome proliferator-activeted receptor gamma. J ClinInvest, 2000, 106:793-802.
6Johnson R A,Kozma F, Colombari E. Carbon monoxide:from toxin to endogenous modulator of cardiovascular functions. Braz J Med Biol Res,1999,32: 1-14.
7Stocker R, Yamanoto Y, Mcdonagh AF, et al. Bilirubin is an antioxidant of possible physiological importanee [J]. Science,1987,235 (4792) : 1043-1046.
8Novotny L, Vitek L. Inverse relationship between serum bilirubin and atherosclerosis in men:a meta-analysis of published studies[J]. Exp Biol Med, 200a, 228(5) : 568-571.
9Schwertner HA. Bilirubin concentration, UGT1A1 * 28 polymorphism, and coronary artery disease [J]. ClinicalChemistry, 2003,49(7) : 1039-1040.
10Hunt SC, Kronenberg F, Eckfeldt JH, et al. Association of plasma bilirubin with coronary heart disease and segregation of bilirubin as a major gene trait: the NHLBI family heart study[J]. Atherosclerosis, 2001,154 (3) : 747-754.
